Hepatocellular Carcinoma Liver Cancer

Antiviral Therapy May Reduce the Risk of Tumor Recurrence in HBV-Related Liver Cancer (11-26-2012)

Patients with hepatitis B-related liver cancer who receive antiviral drugs after curative surgery have a lower risk of recurrence compared to those who do not receive antiviral therapy, according to the results of a study published in the Journal of the... Continue Reading

Sutent® Not Effective for Advanced Liver Cancer (07-10-2009)

In a Phase II clinical trial, patients with inoperable, advanced hepatocellular (liver) cancer did not benefit from treatment with the targeted therapy Sutent® (sunitinib). The results of this study were published in Lancet Oncology. Hepatocellular carcinoma... Continue Reading

Women with Hypothyroidism at Increased Risk of Liver Cancer (06-22-2009)

Women with Hypothyroidism at Increased Risk of Liver Cancer Long-term hypothyroidism in women significantly increases the risk of developing hepatocellular carcinoma (liver cancer), according to the results of a study published in Hepatology.[1] The liver... Continue Reading

Genetic Characteristics of Hepatitis B Associated with Risk of Liver Cancer (03-8-2009)

Genetic Characteristics of Hepatitis B Associated with Risk of Liver Cancer Different genetic characteristics of the hepatitis B virus (HBV) are associated with varying risks of developing hepatocellular carcinoma (HCC), the most common form of liver... Continue Reading

Nexavar® Improves Survival in Advanced Liver Cancer (03-8-2009)

Nexavar® Improves Survival in Advanced Liver Cancer The targeted agent Nexavar (sorafenib) is associated with improved survival and doubling of the time to cancer progression for patients with advanced liver cancer. These results were recently published... Continue Reading

Liver Cancer Screening in Patients with Chronic Hepatitis B and C Improves Survival (03-8-2009)

Liver Cancer Screening in Patients with Chronic Hepatitis B and C Improves Survival Researchers in Hong Kong have reported that screening patients with chronic hepatitis for liver cancer improves liver cancer survival rates and may improve chances for... Continue Reading

Nexavar® Added to Treatment Guidelines for Liver Cancer (03-8-2009)

Nexavar® Added to Treatment Guidelines for Liver Cancer The drug Nexavar® (sorafenib) has been added to the list of treatment options for patients with liver cancer who are not eligible for a liver transplant. This was reported in a recent presentation... Continue Reading

Increased Risk of Liver Cancer for Patients with Cirrhosis Who Overexpress EGF (03-8-2009)

Increased Risk of Liver Cancer for Patients with Cirrhosis Who Overexpress EGF According to an article recently published in the Journal of the American Medical Association, patients with cirrhosis of the liver who overexpress epithelial growth factor... Continue Reading

New Treatment Combination for Bile Duct Cancer May Improve Survival (03-8-2009)

New Treatment Combination for Bile Duct Cancer May Improve Survival A recent study indicates that the combination of photodynamic therapy (PDT) and endoscopic retrograde cholangiopancreatiography (ERCP) may improve survival for patients with bile duct... Continue Reading

Sutent® Active in Liver Cancer (03-8-2009)

Sutent® Active in Liver Cancer Sutent® (sunitinib) reduces the risk of cancer spread and the rate of cancer growth among patients with a form of liver cancer known as hepatocellular carcinoma. These results were presented as a late-breaking abstract... Continue Reading

Next Page »